AAM Applauds FTC-HHS Probe Into Generic Drug Shortages

The Inquiry Will Focus On GPOs and Drug Wholesalers

As two US governmental agencies launch an investigation into the potential causes of drug shortages, AAM says the generics industry faces “unprecedented threats.”

Empty blister pack of tablets, drug shortage concept — Public comments on the shortages investigation are open for 60 days • Source: Shutterstock

In response to the continued efforts to address the ongoing drug shortage crisis, the US Association for Accessible Medicines has commended the country’s Federal Trade Commission and Department of Health and Human Services for their latest bid to “uncover the root causes and potential solutions to drug shortages.”

Last week, the FTC and HHS released a joint Request for Information to understand how pharmaceutical middlemen groups may contribute...